Chen Hailong, Wang Zhilai, Cai Haibo, Zhou Changlin
School of Life Science and Technology, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, Jiangsu, People's Republic of China.
State Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology, Shanghai, 200237, People's Republic of China.
World J Microbiol Biotechnol. 2016 Sep;32(9):153. doi: 10.1007/s11274-016-2102-8. Epub 2016 Jul 27.
S-Adenosyl-L-methionine (SAM), which exists in all living organisms, serves as an activated group donor in a range of metabolic reactions, including trans-methylation, trans-sulfuration and trans-propylamine. Compared with its chemical synthesis and enzyme catalysis production, the microbial production of SAM is feasible for industrial applications. The current clinical demand for SAM is constantly increasing. Therefore, vast interest exists in engineering the SAM metabolism in cells for increasing product titers. Here, we provided an overview of updates on SAM microbial productivity improvements with an emphasis on various strategies that have been used to enhance SAM production based on increasing the precursor and co-factor availabilities in microbes. These strategies included the sections of SAM-producing microbes and their mutant screening, optimization of the fermentation process, and the metabolic engineering. The SAM-producing strains that were used extensively were Saccharomyces cerevisiae, Pichia pastoris, Candida utilis, Scheffersomyces stipitis, Kluyveromyces lactis, Kluyveromyces marxianus, Corynebacterium glutamicum, and Escherichia coli, in addition to others. The optimization of the fermentation process mainly focused on the enhancement of the methionine, ATP, and other co-factor levels through pulsed feeding as well as the optimization of nitrogen and carbon sources. Various metabolic engineering strategies using precise control of gene expression in engineered strains were also highlighted in the present review. In addition, some prospects on SAM microbial production were discussed.
S-腺苷-L-甲硫氨酸(SAM)存在于所有生物体内,在一系列代谢反应中作为活化基团供体,包括转甲基作用、转硫作用和转丙胺作用。与化学合成和酶催化生产相比,SAM的微生物生产在工业应用中是可行的。目前临床对SAM的需求不断增加。因此,人们对改造细胞中的SAM代谢以提高产品滴度有着浓厚的兴趣。在此,我们概述了提高SAM微生物生产力的最新进展,重点介绍了基于提高微生物中前体和辅因子可用性而用于提高SAM产量的各种策略。这些策略包括SAM生产微生物及其突变体筛选、发酵过程优化和代谢工程等方面。除其他菌株外,广泛使用的SAM生产菌株有酿酒酵母、巴斯德毕赤酵母、产朊假丝酵母、树干毕赤酵母、乳酸克鲁维酵母、马克斯克鲁维酵母、谷氨酸棒杆菌和大肠杆菌等。发酵过程的优化主要集中在通过脉冲补料提高甲硫氨酸、ATP和其他辅因子水平以及优化氮源和碳源。本综述还强调了在工程菌株中使用精确基因表达控制的各种代谢工程策略。此外,还讨论了SAM微生物生产的一些前景。